enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series

enVVeno Medical CEO Rob Berman launched a new investor-focused video series called 'WTF Rob Berman,' framing it as straight-talk facts about the company with no corporate spin. Planned topics include the enVVe bioprosthetic venous valve system, the road to the SAVVE pivotal trial, and the company's strategy as it advances toward potential commercialization in severe deep venous insufficiency. The release is purely an investor-communications effort with no new clinical, regulatory, or financial data; roughly 3 million people in the U.S.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.